{
    "title": "112_hr6446",
    "content": "The Act titled \"Improving Diagnostic Innovations Act of 2012\" aims to create incentives for innovative diagnostics. Improvements to the process for determining fee schedule amounts for new clinical diagnostic laboratory tests under the Social Security Act include considering factors like the impact on patient care. The new test focuses on patient care, management, and treatment, technical characteristics, resources needed, claims data, laboratory charges, and private insurance rates. The Secretary convenes an independent advisory panel to provide input on new tests in healthcare, including recommendations and comments from an open meeting. Additional factors may be specified by the Secretary. The Secretary convenes an independent advisory panel of 19 members, including individuals with expertise in clinical diagnostic laboratory tests and representatives of patients, to provide information and recommendations on new tests for payment under the Social Security Act. The Secretary convenes an independent advisory panel of 19 members, including patients, clinicians, experts in test development, laboratorians, pharmacoeconomics experts, and individuals knowledgeable about the impact of new tests on patient care. The Secretary appoints a panel of 19 members with expertise in various fields to serve staggered 6-year terms. Expert consultants may be temporarily included on the panel. The Secretary must hold open meetings to review findings and recommendations related to new tests, allowing for public comment. The Secretary establishes a process for assigning temporary national HCPCS codes to identify diagnostic tests until permanent codes are available. Assignments occur quarterly, with public notice provided on the CMS website. The Secretary establishes a process for assigning temporary national HCPCS codes to identify diagnostic tests until permanent codes are available. Assignments occur quarterly, with public notice provided on the CMS website. The Secretary shall analyze and improve the gapfilling procedure for determining payment amounts for new clinical diagnostic laboratory tests under the Social Security Act. This includes identifying changes to improve accuracy, transparency, and accountability in the rate-setting process. The Secretary will implement improvements in the process for assigning temporary national HCPCS codes for new clinical diagnostic laboratory tests. Recommendations for changes requiring a change in law will be transmitted to the Speaker of the House and the President of the Senate by July 1, 2013. Definitions for \"new clinical diagnostic laboratory tests\" and \"self-pay patient\" are provided. The term \"self-pay patient\" refers to an individual who pays out of pocket for a health care item or service without insurance coverage. This section will be effective upon the enactment of the Act and applies to new clinical diagnostic laboratory tests."
}